{"title":"回缩：LINC01133通过调节miR-30a-5p/FOXD1促进宫颈癌症的进展。","authors":"","doi":"10.1111/ajco.13997","DOIUrl":null,"url":null,"abstract":"<p><b>Retraction</b>: Zhang D, Zhang Y, Sun X. LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1. <i>Asia-Pac J Clin Oncol</i>. 2021;17:253-263. https://doi.org/10.1111/ajco.13451. The above article, published online on 20 October 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal's Editors-in-Chief, Professor Stephen Ackland and Professor Mengzhao Wang, and John Wiley & Sons Australia, Ltd. Following publication, concerns were raised by third parties regarding possible image duplication within Figures 2, 4 and 6. Upon investigation by the editorial team, it was concluded that several image elements of the experimental data were duplicated within figures in the article, or had already been published elsewhere in a different scientific context. Thus, the editors consider the conclusions of this article to no longer be reliable.</p>","PeriodicalId":8633,"journal":{"name":"Asia-Pacific journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajco.13997","citationCount":"0","resultStr":"{\"title\":\"Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1\",\"authors\":\"\",\"doi\":\"10.1111/ajco.13997\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><b>Retraction</b>: Zhang D, Zhang Y, Sun X. LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1. <i>Asia-Pac J Clin Oncol</i>. 2021;17:253-263. https://doi.org/10.1111/ajco.13451. The above article, published online on 20 October 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal's Editors-in-Chief, Professor Stephen Ackland and Professor Mengzhao Wang, and John Wiley & Sons Australia, Ltd. Following publication, concerns were raised by third parties regarding possible image duplication within Figures 2, 4 and 6. Upon investigation by the editorial team, it was concluded that several image elements of the experimental data were duplicated within figures in the article, or had already been published elsewhere in a different scientific context. Thus, the editors consider the conclusions of this article to no longer be reliable.</p>\",\"PeriodicalId\":8633,\"journal\":{\"name\":\"Asia-Pacific journal of clinical oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2023-10-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajco.13997\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asia-Pacific journal of clinical oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/ajco.13997\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia-Pacific journal of clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ajco.13997","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
撤稿:张丹，张颖，孙鑫。LINC01133通过调控miR-30a-5p/FOXD1促进宫颈癌的进展。中华临床医学杂志，2011;17(2):563 - 563。https://doi.org/10.1111/ajco.13451。上述文章于2020年10月20日在线发表在Wiley在线图书馆(wileyonlinelibrary.com)上，经该杂志主编Stephen Ackland教授和Mengzhao Wang教授以及John Wiley & Sons Australia, Ltd.同意撤回。出版后，第三方对图2、图4和图6中可能出现的图像重复表示关注。经过编辑团队的调查，得出的结论是，实验数据的几个图像元素在文章中的数字中重复，或者已经在其他地方发表在不同的科学背景下。因此，编辑认为本文的结论不再可靠。
Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1
Retraction: Zhang D, Zhang Y, Sun X. LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1. Asia-Pac J Clin Oncol. 2021;17:253-263. https://doi.org/10.1111/ajco.13451. The above article, published online on 20 October 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal's Editors-in-Chief, Professor Stephen Ackland and Professor Mengzhao Wang, and John Wiley & Sons Australia, Ltd. Following publication, concerns were raised by third parties regarding possible image duplication within Figures 2, 4 and 6. Upon investigation by the editorial team, it was concluded that several image elements of the experimental data were duplicated within figures in the article, or had already been published elsewhere in a different scientific context. Thus, the editors consider the conclusions of this article to no longer be reliable.
期刊介绍：
Asia–Pacific Journal of Clinical Oncology is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia–Pacific region in relation to cancer treatment and care. The Journal is ideally positioned to receive publications that deal with diversity in cancer behavior, management and outcome related to ethnic, cultural, economic and other differences between populations. In addition to original articles, the Journal publishes reviews, editorials, letters to the Editor and short communications. Case reports are generally not considered for publication, only exceptional papers in which Editors find extraordinary oncological value may be considered for review. The Journal encourages clinical studies, particularly prospectively designed clinical trials.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
